II
PBYI icon

Inspire Investing’s Puma Biotechnology PBYI Stock Holding History

Inspire Investing’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39 Hold
5
– – ﹤0.01% 1242
2026
Q1 		$31 Hold
5
– – ﹤0.01% 1085
2025
Q4 		$31 Buy
+5
New +$27 ﹤0.01% 1088
2020
Q2 		– Sell
-41
Closed – – 655
2020
Q1 		$0 Sell
41
-21,350
-100% -$207K ﹤0.01% 778
2019
Q4 		$187K Buy
21,391
+5,494
+35% +$45.5K 0.07% 286
2019
Q3 		$171K Buy
15,897
+3,658
+30% +$39.5K 0.07% 360
2019
Q2 		$156K Buy
+12,239
New +$282K 0.07% 324
2018
Q1 		– Sell
-590
Closed -$58K – 551
2017
Q4 		$58K Buy
+590
New +$66K 0.05% 404

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inspire Investing's PBYI Position: Q2 2026 in Review

Inspire Investing held its Puma Biotechnology (PBYI) position steady in Q2 2026 at 5 shares worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Inspire Investing first reported a position in PBYI in Q4 2017 and has held it in 8 quarters since. The position peaked at $187K in Q4 2019. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Inspire Investing held 5 shares of Puma Biotechnology worth $39 as of Q2 2026.
  • Inspire Investing left its Puma Biotechnology share count unchanged in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1242 holding.
  • Inspire Investing first reported a position in Puma Biotechnology in Q4 2017 and has held it in 8 quarters since.
  • Inspire Investing's Puma Biotechnology position peaked at $187K in Q4 2019.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.